232 related articles for article (PubMed ID: 31770556)
21. Preparation and characterization of microparticles of β-cyclodextrin/glutathione and chitosan/glutathione obtained by spray-drying.
Webber V; de Siqueira Ferreira D; Barreto PLM; Weiss-Angeli V; Vanderlinde R
Food Res Int; 2018 Mar; 105():432-439. PubMed ID: 29433233
[TBL] [Abstract][Full Text] [Related]
22. Preparation of cross-linked chitosan microspheres by spray drying: effect of cross-linking agent on the properties of spray dried microspheres.
Desai KG; Park HJ
J Microencapsul; 2005 Jun; 22(4):377-95. PubMed ID: 16214786
[TBL] [Abstract][Full Text] [Related]
23. Drying Using Supercritical Fluid Technology as a Potential Method for Preparation of Chitosan Aerogel Microparticles.
Obaidat RM; Tashtoush BM; Bayan MF; Al Bustami RT; Alnaief M
AAPS PharmSciTech; 2015 Dec; 16(6):1235-44. PubMed ID: 25761387
[TBL] [Abstract][Full Text] [Related]
24. Chitosan for improved encapsulation of thyme aqueous extract in alginate-based microparticles.
Diana G; Candiani A; Picco A; Milanesi A; Stampini M; Bari E; Torre ML; Segale L; Giovannelli L
Int J Biol Macromol; 2024 Jun; 270(Pt 2):132493. PubMed ID: 38763251
[TBL] [Abstract][Full Text] [Related]
25. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterisation of alendronate-loaded chitosan microparticles obtained through the spray drying technique.
Ochiuz L; Peris JE
Med Chem; 2009 Mar; 5(2):191-6. PubMed ID: 19275718
[TBL] [Abstract][Full Text] [Related]
27. Investigations of the Influences of Processing Conditions on the Properties of Spray Dried Chitosan-Tripolyphosphate Particles loaded with Theophylline.
Wei Y; Huang YH; Cheng KC; Song YL
Sci Rep; 2020 Jan; 10(1):1155. PubMed ID: 31980705
[TBL] [Abstract][Full Text] [Related]
28. Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment.
Mukhopadhyay P; Maity S; Mandal S; Chakraborti AS; Prajapati AK; Kundu PP
Carbohydr Polym; 2018 Feb; 182():42-51. PubMed ID: 29279124
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of microparticle protein delivery systems based on calcium alginate.
Yu CY; Jia LH; Cheng SX; Zhang XZ; Zhuo RX
J Microencapsul; 2010; 27(2):171-7. PubMed ID: 19538029
[TBL] [Abstract][Full Text] [Related]
30. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
31. Chitosan microparticles for the controlled delivery of fluoride.
Keegan GM; Smart JD; Ingram MJ; Barnes LM; Burnett GR; Rees GD
J Dent; 2012 Mar; 40(3):229-40. PubMed ID: 22212236
[TBL] [Abstract][Full Text] [Related]
32. Characterization of biologically active insulin-loaded alginate microparticles prepared by spray drying.
Bowey K; Swift BE; Flynn LE; Neufeld RJ
Drug Dev Ind Pharm; 2013 Mar; 39(3):457-65. PubMed ID: 22397581
[TBL] [Abstract][Full Text] [Related]
33. Properties of a Stable and Sustained-Release Formulation of Recombinant Human Parathyroid Hormone (rhPTH) with Chitosan and Silk Fibroin Microparticles.
Lv BH; Tan W; Zhu CC; Shang X; Zhang L
Med Sci Monit; 2018 Oct; 24():7532-7540. PubMed ID: 30345994
[TBL] [Abstract][Full Text] [Related]
34. Influence of post-emulsification drying processes on the microencapsulation of human serum albumin.
Lane ME; Brennan FS; Corrigan OI
Int J Pharm; 2006 Jan; 307(1):16-22. PubMed ID: 16274944
[TBL] [Abstract][Full Text] [Related]
35. Toxicity and gut associated lymphoid tissue translocation of polymyxin B orally administered by alginate/chitosan microparticles in rats.
Coppi G; Bondi M; Coppi A; Rossi T; Sergi S; Iannuccelli V
J Pharm Pharmacol; 2008 Jan; 60(1):21-6. PubMed ID: 18088501
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of theophylline loaded chitosan/beta-cyclodextrin microspheres.
Zhang WF; Chen XG; Li PW; He QZ; Zhou HY
J Mater Sci Mater Med; 2008 Jan; 19(1):305-10. PubMed ID: 17597373
[TBL] [Abstract][Full Text] [Related]
37. Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies.
Gavini E; Rassu G; Sanna V; Cossu M; Giunchedi P
J Pharm Pharmacol; 2005 Mar; 57(3):287-94. PubMed ID: 15807983
[TBL] [Abstract][Full Text] [Related]
38. Chitosan oligosaccharide as prospective cross-linking agent for naproxen-loaded Ca-alginate microparticles with improved pH sensitivity.
Čalija B; Milić J; Cekić N; Krajišnik D; Daniels R; Savić S
Drug Dev Ind Pharm; 2013 Jan; 39(1):77-88. PubMed ID: 22339172
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of burst release from pH-responsive polymeric microparticles.
Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
[TBL] [Abstract][Full Text] [Related]
40. Calcium alginate microparticles for oral administration: I: Effect of sodium alginate type on drug release and drug entrapment efficiency.
Takka S; Acartürk F
J Microencapsul; 1999; 16(3):275-90. PubMed ID: 10340214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]